Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen.
Journal
Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435
Informations de publication
Date de publication:
05 Sep 2024
05 Sep 2024
Historique:
received:
14
05
2024
medline:
5
9
2024
pubmed:
5
9
2024
entrez:
5
9
2024
Statut:
aheadofprint
Résumé
Not available.
Identifiants
pubmed: 39234873
doi: 10.3324/haematol.2024.285837
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM